Neumora Therapeutics, Inc.(NMRA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

NMRA Neumora Therapeutics, Inc.

盘后交易 09-18 19:44:35 EDT

1.57

+0.12

+8.28%

盘后1.59

+0.02+1.27%

19:40 EDT

最高1.57	最低1.43	成交量41.02万
今开1.44	昨收1.45	日振幅9.66%
总市值2.54亿	流通市值1.35亿	总股本1.62亿
成交额61.87万	换手率0.48%	流通股本8,606万
市净率1.39	ROE-89.37%	每股收益-1.57
52周最高17.19	52周最低0.6110	市盈率-1.00
股息0.00	股息收益率0.00	ROA-52.63%

北京优虎网络科技有限公司

{"stockData":{"symbol":"NMRA","market":"US","secType":"STK","nameCN":"Neumora Therapeutics, Inc.","latestPrice":1.57,"timestamp":1758225600000,"preClose":1.45,"halted":0,"volume":410248,"hourTrading":{"tag":"盘后","latestPrice":1.59,"preClose":1.57,"latestTime":"19:40 EDT","volume":26898,"amount":42508.765362,"timestamp":1758238825513},"delay":0,"floatShares":86062982,"shares":161945427,"eps":-1.566441,"marketStatus":"盘后交易","change":0.12,"latestTime":"09-18 19:44:31 EDT","open":1.44,"high":1.57,"low":1.43,"amount":618741.2437496,"amplitude":0.096552,"askPrice":1.7,"askSize":200,"bidPrice":1.45,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.566441,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1758240000000},"marketStatusCode":4,"adr":0,"listingDate":1694750400000,"exchange":"NASDAQ","adjPreClose":1.45,"preHourTrading":{"tag":"盘前","latestPrice":1.45,"preClose":1.45,"latestTime":"09:11 EDT","volume":761,"amount":1107.1595705999998,"timestamp":1758201073602},"postHourTrading":{"tag":"盘后","latestPrice":1.59,"preClose":1.57,"latestTime":"19:40 EDT","volume":26898,"amount":42508.765362,"timestamp":1758238825513},"volumeRatio":0.8282,"impliedVol":1.6666,"impliedVolPercentile":0.484},"requestUrl":"/m/hq/s/NMRA","defaultTab":"news","newsList":[{"id":"2553426987","title":"瑞穗：核心新药NMRA-861销售有望达12亿美元 上调Neumora(NMRA.US)目标价至5美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553426987","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553426987?lang=zh_cn&edition=full","pubTime":"2025-07-21 14:35","pubTimestamp":1753079726,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，瑞穗分析师Graig Suvannavejh发表研报，将Neumora Therapeutics目标价从4美元上调至5美元，并维持“跑赢大盘”评级。此次评级调整源于Neumora在7月9日宣布启动NMRA-861的一期临床试验。NMRA-861是一种高效、选择性正向变构调节剂，该公司正开发其用于治疗精神分裂症及其他神经精神类疾病。瑞穗预测，该药物有望于2034年在美国上市，经风险调整前测算，NMRA-861在2037年的销售额或将达到12亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1319975.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"瑞穗：核心新药NMRA-861销售有望达12亿美元 上调Neumora(NMRA.US)目标价至5美元","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["NMRA"],"gpt_icon":0},{"id":"2548829651","title":"Neumora Therapeutics, Inc.7月2日成交额为91.08万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548829651","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548829651?lang=zh_cn&edition=full","pubTime":"2025-07-03 12:20","pubTimestamp":1751516425,"startTime":"0","endTime":"0","summary":"美东时间2025年7月2日，Neumora Therapeutics, Inc.成交额为91.08万美元，成交额较昨日增加20.11%，当日成交量为113.66万股。Neumora Therapeutics, Inc.于2025年7月2日跌1.77%，报0.782美元，该股过去5个交易日跌3.19%，年初至今跌92.62%，过去60日涨6.13%。该公司已扩大其治疗产品线，目前包括七个临床和临床前神经科学项目，旨在针对一系列未得到充分治疗的神经精神障碍和神经退行性疾病的新型作用机制。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703122032a72bdfbf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703122032a72bdfbf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4539","BK4007","NMRA"],"gpt_icon":0},{"id":"2546775205","title":"Neumora Therapeutics, Inc.6月27日成交额为825.20万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546775205","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546775205?lang=zh_cn&edition=full","pubTime":"2025-06-28 12:02","pubTimestamp":1751083371,"startTime":"0","endTime":"0","summary":"美东时间2025年6月27日，Neumora Therapeutics, Inc.成交额为825.20万美元，成交额较昨日增加1414.91%，当日成交量为1085.40万股。Neumora Therapeutics, Inc.于2025年6月27日跌5.32%，报0.757美元，该股过去5个交易日跌3.7%，年初至今跌92.86%，过去60日跌17.1%。该公司已扩大其治疗产品线，目前包括七个临床和临床前神经科学项目，旨在针对一系列未得到充分治疗的神经精神障碍和神经退行性疾病的新型作用机制。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628120300a7220aa0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628120300a7220aa0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","BK4007","NMRA","LENZ"],"gpt_icon":0},{"id":"2542498538","title":"Neumora Therapeutics, Inc.盘中异动 早盘股价大跌6.56%报0.953美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542498538","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542498538?lang=zh_cn&edition=full","pubTime":"2025-06-11 22:25","pubTimestamp":1749651958,"startTime":"0","endTime":"0","summary":"北京时间2025年06月11日22时25分，Neumora Therapeutics, Inc.股票出现波动，股价急速下挫6.56%。Neumora Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.11%。Neumora Therapeutics, Inc.公司简介：Neumora Therapeutics Inc 是一家临床阶段的生物制药公司，成立的初衷是通过采用一种全新的方法来开发脑部疾病治疗方案，以应对脑部疾病危机。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611222558a703cf70&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611222558a703cf70&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NMRA","BK4139","LENZ","BK4539","BK4007"],"gpt_icon":0},{"id":"2542387062","title":"Neumora Therapeutics, Inc.股价上涨13.26% 市值涨2168.46万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542387062","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542387062?lang=zh_cn&edition=full","pubTime":"2025-06-09 21:31","pubTimestamp":1749475878,"startTime":"0","endTime":"0","summary":"北京时间2025年06月09日21时31分，Neumora Therapeutics, Inc.股票出现波动，股价大幅拉升13.26%。Neumora Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.45%。Neumora Therapeutics, Inc.公司简介：Neumora Therapeutics Inc 是一家临床阶段的生物制药公司，成立的初衷是通过采用一种全新的方法来开发脑部疾病治疗方案，以应对脑部疾病危机。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250609213118a700af16&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250609213118a700af16&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NMRA","BK4007","LENZ","BK4539"],"gpt_icon":0},{"id":"2537137636","title":"Neumora Therapeutics, Inc.盘中异动 早盘股价大跌5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537137636","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537137636?lang=zh_cn&edition=full","pubTime":"2025-05-23 22:12","pubTimestamp":1748009561,"startTime":"0","endTime":"0","summary":"北京时间2025年05月23日22时12分，Neumora Therapeutics, Inc.股票出现波动，股价快速下跌5.24%。Neumora Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.04%。Neumora Therapeutics, Inc.公司简介：Neumora Therapeutics Inc 是一家临床阶段的生物制药公司，成立的初衷是通过采用一种全新的方法来开发脑部疾病治疗方案，以应对脑部疾病危机。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523221241950086cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523221241950086cb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","LENZ","BK4139","BK4007","NMRA"],"gpt_icon":0},{"id":"2537395698","title":"Neumora Therapeutics, Inc.盘中异动 临近收盘股价大涨5.52%报0.770美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537395698","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537395698?lang=zh_cn&edition=full","pubTime":"2025-05-22 03:45","pubTimestamp":1747856712,"startTime":"0","endTime":"0","summary":"北京时间2025年05月22日03时45分，Neumora Therapeutics, Inc.股票出现波动，股价急速拉升5.52%。Neumora Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.98%。Neumora Therapeutics, Inc.公司简介：Neumora Therapeutics Inc 是一家临床阶段的生物制药公司，成立的初衷是通过采用一种全新的方法来开发脑部疾病治疗方案，以应对脑部疾病危机。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522034512aa2c962b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522034512aa2c962b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","LENZ","BK4139","NMRA","BK4007"],"gpt_icon":0},{"id":"2537647483","title":"Neumora Therapeutics, Inc.盘中异动 下午盘快速上涨5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537647483","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537647483?lang=zh_cn&edition=full","pubTime":"2025-05-21 01:47","pubTimestamp":1747763272,"startTime":"0","endTime":"0","summary":"北京时间2025年05月21日01时47分，Neumora Therapeutics, Inc.股票出现波动，股价大幅拉升5.18%。Neumora Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.69%。Neumora Therapeutics, Inc.公司简介：Neumora Therapeutics Inc 是一家临床阶段的生物制药公司，成立的初衷是通过采用一种全新的方法来开发脑部疾病治疗方案，以应对脑部疾病危机。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521014752aa2c9464&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521014752aa2c9464&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NMRA","LENZ","BK4139","BK4539"],"gpt_icon":0},{"id":"2536680895","title":"Neumora Therapeutics, Inc.盘中异动 早盘大幅下跌5.92%报0.660美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2536680895","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536680895?lang=zh_cn&edition=full","pubTime":"2025-05-19 21:31","pubTimestamp":1747661493,"startTime":"0","endTime":"0","summary":"北京时间2025年05月19日21时31分，Neumora Therapeutics, Inc.股票出现波动，股价急速下挫5.92%。Neumora Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.17%。Neumora Therapeutics, Inc.公司简介：Neumora Therapeutics Inc 是一家临床阶段的生物制药公司，成立的初衷是通过采用一种全新的方法来开发脑部疾病治疗方案，以应对脑部疾病危机。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051921313394fb92d1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051921313394fb92d1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","BK4007","LENZ","NMRA"],"gpt_icon":0},{"id":"2536059100","title":"Neumora Therapeutics, Inc.2025财年第一财季实现净利润-67.99百万美元，同比减少26.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536059100","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536059100?lang=zh_cn&edition=full","pubTime":"2025-05-19 00:00","pubTimestamp":1747584035,"startTime":"0","endTime":"0","summary":"5月19日，Neumora Therapeutics, Inc.公布财报，公告显示公司2025财年第一财季净利润为-67.99百万美元，同比减少26.56%；其中营业收入为0.00美元，每股基本收益为-0.42美元。机构评级：截至2025年5月19日，当前有6家机构对Neumora Therapeutics, Inc.目标价做出预测，其中目标均价为5.67美元，其中最低目标价为1.00美元，最高目标价为18.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519000138a482f002&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519000138a482f002&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","NMRA"],"gpt_icon":0},{"id":"2535315026","title":"Neumora Therapeutics, Inc.盘中异动 早盘大幅拉升5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2535315026","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535315026?lang=zh_cn&edition=full","pubTime":"2025-05-16 21:50","pubTimestamp":1747403420,"startTime":"0","endTime":"0","summary":"北京时间2025年05月16日21时50分，Neumora Therapeutics, Inc.股票出现波动，股价大幅拉升5.14%。Neumora Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.09%。Neumora Therapeutics, Inc.公司简介：Neumora Therapeutics Inc 是一家临床阶段的生物制药公司，成立的初衷是通过采用一种全新的方法来开发脑部疾病治疗方案，以应对脑部疾病危机。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516215020975bdc8a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516215020975bdc8a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","BK4539","LENZ","NMRA"],"gpt_icon":0},{"id":"2535887789","title":"Neumora Therapeutics, Inc.盘中异动 股价大涨5.46%报0.649美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535887789","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535887789?lang=zh_cn&edition=full","pubTime":"2025-05-16 02:38","pubTimestamp":1747334289,"startTime":"0","endTime":"0","summary":"北京时间2025年05月16日02时38分，Neumora Therapeutics, Inc.股票出现异动，股价急速拉升5.46%。截至发稿，该股报0.649美元/股，成交量57.6051万股，换手率0.36%，振幅4.41%。Neumora Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.96%。Neumora Therapeutics, Inc.公司简介：Neumora Therapeutics Inc 是一家临床阶段的生物制药公司，成立的初衷是通过采用一种全新的方法来开发脑部疾病治疗方案，以应对脑部疾病危机。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516023809a47fe7e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516023809a47fe7e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NMRA","BK4007","LENZ","BK4539"],"gpt_icon":0},{"id":"2535402079","title":"Neumora Therapeutics, Inc.盘中异动 早盘股价大跌5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2535402079","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535402079?lang=zh_cn&edition=full","pubTime":"2025-05-14 22:27","pubTimestamp":1747232852,"startTime":"0","endTime":"0","summary":"北京时间2025年05月14日22时27分，Neumora Therapeutics, Inc.股票出现波动，股价急速跳水5.28%。Neumora Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.29%。Neumora Therapeutics, Inc.公司简介：Neumora Therapeutics Inc 是一家临床阶段的生物制药公司，成立的初衷是通过采用一种全新的方法来开发脑部疾病治疗方案，以应对脑部疾病危机。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514222732975991d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514222732975991d2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","BK4539","NMRA","LENZ"],"gpt_icon":0},{"id":"2534487550","title":"Neumora Therapeutics, Inc.盘中异动 早盘快速拉升7.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2534487550","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534487550?lang=zh_cn&edition=full","pubTime":"2025-05-09 21:31","pubTimestamp":1746797471,"startTime":"0","endTime":"0","summary":"北京时间2025年05月09日21时31分，Neumora Therapeutics, Inc.股票出现波动，股价快速拉升7.69%。Neumora Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.17%。Neumora Therapeutics, Inc.公司简介：Neumora Therapeutics Inc 是一家临床阶段的生物制药公司，成立的初衷是通过采用一种全新的方法来开发脑部疾病治疗方案，以应对脑部疾病危机。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509213112aa2c88cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509213112aa2c88cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NMRA","LENZ","BK4139","BK4539","BK4007"],"gpt_icon":0},{"id":"2533936308","title":"Neumora Therapeutics, Inc.盘中异动 早盘股价大涨7.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533936308","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533936308?lang=zh_cn&edition=full","pubTime":"2025-05-07 21:31","pubTimestamp":1746624672,"startTime":"0","endTime":"0","summary":"北京时间2025年05月07日21时31分，Neumora Therapeutics, Inc.股票出现异动，股价急速上涨7.34%。Neumora Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.09%。Neumora Therapeutics, Inc.公司简介：Neumora Therapeutics Inc 是一家临床阶段的生物制药公司，成立的初衷是通过采用一种全新的方法来开发脑部疾病治疗方案，以应对脑部疾病危机。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507213112a4756e06&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507213112a4756e06&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","NMRA","BK4139","BK4007"],"gpt_icon":0},{"id":"2532200550","title":"Neumora Therapeutics, Inc.盘中异动 急速跳水5.07%报0.740美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532200550","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532200550?lang=zh_cn&edition=full","pubTime":"2025-05-01 21:51","pubTimestamp":1746107511,"startTime":"0","endTime":"0","summary":"北京时间2025年05月01日21时51分，Neumora Therapeutics, Inc.股票出现异动，股价急速下挫5.07%。Neumora Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.30%。Neumora Therapeutics, Inc.公司简介：Neumora Therapeutics Inc 是一家临床阶段的生物制药公司，成立的初衷是通过采用一种全新的方法来开发脑部疾病治疗方案，以应对脑部疾病危机。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501215151974c99bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501215151974c99bd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4007","NMRA"],"gpt_icon":0},{"id":"2529568782","title":"Neumora Therapeutics, Inc.盘中异动 早盘大幅上涨6.18%报0.749美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529568782","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529568782?lang=zh_cn&edition=full","pubTime":"2025-04-23 21:31","pubTimestamp":1745415062,"startTime":"0","endTime":"0","summary":"北京时间2025年04月23日21时31分，Neumora Therapeutics, Inc.股票出现异动，股价大幅拉升6.18%。Neumora Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.57%。Neumora Therapeutics, Inc.公司简介：Neumora Therapeutics Inc 是一家临床阶段的生物制药公司，成立的初衷是通过采用一种全新的方法来开发脑部疾病治疗方案，以应对脑部疾病危机。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423213102a6c53c30&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423213102a6c53c30&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","NMRA","BK4139"],"gpt_icon":0},{"id":"2529534287","title":"Neumora Therapeutics, Inc.盘中异动 股价大涨5.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529534287","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529534287?lang=zh_cn&edition=full","pubTime":"2025-04-23 00:35","pubTimestamp":1745339743,"startTime":"0","endTime":"0","summary":"北京时间2025年04月23日00时35分，Neumora Therapeutics, Inc.股票出现波动，股价大幅拉升5.42%。Neumora Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为2.03%。Neumora Therapeutics, Inc.公司简介：Neumora Therapeutics Inc 是一家临床阶段的生物制药公司，成立的初衷是通过采用一种全新的方法来开发脑部疾病治疗方案，以应对脑部疾病危机。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042300354394de5eab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042300354394de5eab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","NMRA","BK4007"],"gpt_icon":0},{"id":"2528374504","title":"Neumora Therapeutics, Inc.盘中异动 快速上涨5.51%报0.665美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2528374504","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528374504?lang=zh_cn&edition=full","pubTime":"2025-04-17 21:52","pubTimestamp":1744897953,"startTime":"0","endTime":"0","summary":"北京时间2025年04月17日21时52分，Neumora Therapeutics, Inc.股票出现波动，股价大幅上涨5.51%。Neumora Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.40%。Neumora Therapeutics, Inc.公司简介：Neumora Therapeutics Inc 是一家临床阶段的生物制药公司，成立的初衷是通过采用一种全新的方法来开发脑部疾病治疗方案，以应对脑部疾病危机。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417215233a45ca16e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417215233a45ca16e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","NMRA","BK4007"],"gpt_icon":0},{"id":"2527829422","title":"Neumora Therapeutics, Inc.盘中异动 大幅跳水5.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527829422","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527829422?lang=zh_cn&edition=full","pubTime":"2025-04-16 02:42","pubTimestamp":1744742535,"startTime":"0","endTime":"0","summary":"北京时间2025年04月16日02时42分，Neumora Therapeutics, Inc.股票出现异动，股价大幅下跌5.63%。Neumora Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.55%。Neumora Therapeutics, Inc.公司简介：Neumora Therapeutics Inc 是一家临床阶段的生物制药公司，成立的初衷是通过采用一种全新的方法来开发脑部疾病治疗方案，以应对脑部疾病危机。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416024215a45a0ddc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416024215a45a0ddc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","NMRA","LENZ","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.neumoratx.com","stockEarnings":[{"period":"1week","weight":-0.1104},{"period":"1month","weight":-0.1159},{"period":"3month","weight":0.859},{"period":"6month","weight":0.2832},{"period":"1year","weight":-0.8764},{"period":"ytd","weight":-0.8632}],"compareEarnings":[{"period":"1week","weight":0.0107},{"period":"1month","weight":0.0247},{"period":"3month","weight":0.1033},{"period":"6month","weight":0.1688},{"period":"1year","weight":0.1707},{"period":"ytd","weight":0.1247}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Neumora Therapeutics, Inc.成立于2019年11月，当时是一家特拉华州公司，名称为RBNC Therapeutics, Inc.。该公司于2021年10月更名为Neumora Therapeutics, Inc.。该公司是一家临床阶段的生物制药公司，旨在应对全球脑部疾病危机，对脑部疾病的治疗方法采取一种根本不同的方法。该公司的治疗管道规模迅速扩大，目前包括七个临床和临床前神经科学项目，针对广泛的未得到充分服务的神经精神疾病和神经退行性疾病的新的作用机制。该公司最先进的候选产品navacaprant（NMRA-140）是一种新型的每日一次口服kappa阿片受体（KOR）拮抗剂，正在开发用于治疗重度抑郁症（MDD），该公司认为，如果获得批准，这种药物有可能提供相对于标准护理的显著优势。","exchange":"NASDAQ","name":"Neumora Therapeutics, Inc.","nameEN":"Neumora Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.3","shortVersion":"4.35.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Neumora Therapeutics, Inc.(NMRA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Neumora Therapeutics, Inc.(NMRA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Neumora Therapeutics, Inc.,NMRA,Neumora Therapeutics, Inc.股票,Neumora Therapeutics, Inc.股票老虎,Neumora Therapeutics, Inc.股票老虎国际,Neumora Therapeutics, Inc.行情,Neumora Therapeutics, Inc.股票行情,Neumora Therapeutics, Inc.股价,Neumora Therapeutics, Inc.股市,Neumora Therapeutics, Inc.股票价格,Neumora Therapeutics, Inc.股票交易,Neumora Therapeutics, Inc.股票购买,Neumora Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Neumora Therapeutics, Inc.(NMRA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Neumora Therapeutics, Inc.(NMRA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}